GNS Co-Founder Iya Khalil Interviewed in The Pink Sheet

At the 2017 BIO International Convention, GNS Co-Founder and Chief Commercial Officer Iya Khalil sat down with Laura Helbling, the Director of Research at Prevision Policy and a Senior Writer at Pink Sheet to discuss machine learning in drug development. The conversation focused on how GNS’ causal machine learning and simulation platform applied to massive […]